A new robust statistical model for interpretation of differences in serial test results from an individual

Clinical Chemistry and Laboratory Medicine

Volumn 53, Issue 5, 2015, Pages 815-822

  Braga, Federica ^a   Ferraro, Simona ^a   Ieva, Francesca ^b   Paganoni, Anna ^c   Panteghini, Mauro ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c POLITECNICO DI MILANO   (Italy)

Author keywords

biological variability; laboratory tests; reference change value

Indexed keywords

C REACTIVE PROTEIN; CHROMOGRANIN A; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ARTICLE; CALCULATION; HUMAN; LABORATORY TEST; MEASUREMENT; PRIORITY JOURNAL; SIMULATION; STATISTICAL ANALYSIS; STATISTICAL MODEL; VALIDATION STUDY; BLOOD; BLOOD ANALYSIS; REFERENCE VALUE; STANDARDS;

BLOOD CHEMICAL ANALYSIS; C-REACTIVE PROTEIN; CHROMOGRANIN A; DATA INTERPRETATION, STATISTICAL; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MODELS, STATISTICAL; REFERENCE VALUES;

EID: 84928019941     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-0893     Document Type: Article

References (28)

1. Ceriotti F, Hinzmann R, Panteghini M. Reference intervals: the way forward. Ann Clin Biochem 2009;46:8-17.
2. Harris EK. Effects of intra- and inter-individual variation on the appropriate use of normal range. Clin Chem 1974;20:1535-42.
3. Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989;27:409-37.
4. Fraser CG. Making better use of differences in serial laboratory results. Ann Clin Biochem 2012;49:1-3.
5. Fraser CG. Reference change values. Clin Chem Lab Med 2012;50:807-12.
6. Fraser CG. Biological variaton: from principles to practice. Washington, DC: AACC Press, 2001.
7. Harris EK, Yasaka T. On the calculation of a "reference change" for comparing two consecutive measurements. Clin Chem 1983;29:25-30.
8. Ferraro S, Panteghini M. Is serum human epididymis protein 4 ready for prime time? Ann Clin Biochem 2014;51:128-36.
9. Fraser CG, Stevenson HP, Kennedy IM. Biological variation data are necessary prerequisites for objective autoverification of clinical laboratory data. Accred Qual Assur 2002;7:455-60.
10. Franzini C. Need for correct estimates of biological variation: the example of C-reactive protein. Clin Chem Lab Med 1998;36: 131-2.
11. Fokkema MR, Herrmann Z, Muskiet FA, Moecks J. Reference change values for brain natriuretic peptides revisited. Clin Chem 2006;52:1602-3.
12. Braga F, Ferraro S, Lanzoni M, Szoke D, Panteghini M. Estimate of intraindividual variability of C-reactive protein: a challenging issue. Clin Chim Acta 2013;419:85-6.
13. Braga F, Panteghini M. Biologic variability of C-reactive protein: is the available information reliable? Clin Chim Acta 2012;413:1179-83.
14. Sullivan LM. Repeated measures. Circulation 2008;117:1238-43.
15. Peters JL, Mengersen KL. Meta-analysis of repeated measures study designs. J Eval Clin Pract 2008;14:941-50.
16. Røraas T, Petersen H, Sandberg S. Confidence intervals and power calculations for within-person biological variation: effect of analytical imprecision, number of replicates, number of samples and number of individual. Clin Chem 2012;58:1306-13.
17. Fraser CG. Reference change values: the way forward in monitoring. Ann Clin Biochem 2009;46:264-5.
18. Garner AE, Lewington AJ, Barth JH. Detection of patients with acute kidney injury by the clinical laboratory using rises in serum creatinine: comparison of proposed definitions and a laboratory delta check. Ann Clin Biochem 2012;49:59-62.
19. rd ed. Oxford: Oxford University, 2000.
20. Braga F, Dolci A, Montagnana M, Pagani F, Paleari R, Guidi GC, et al. Revaluation of biological variation of glycated hemoglobin (HbA1c) using an accurately designed protocol and an assay traceable to the IFCC reference system. Clin Chim Acta 2011;412:1412-6.
21. Braga F, Ferraro S, Mozzi R, Dolci A, Panteghini M. Biological variation of neuroendocrine tumor markers chromogranin A and neuron-specific enolase. Clin Biochem 2013;46:148-51.
22. Ferraro S, Mozzi R, Michelazzo C, Basco D, Panteghini M. Reference intervals for the new Brahms chromogranin A (CGA) assay. Biochim Clin 2013;37:S169.
23. Ricós C, Cava F, García-Lario JV, Hernández A, Iglesias N, Jiménez CV, et al. The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation. Scand J Clin Lab Invest 2004;64:175-84.
24. Cooper G, DeJonge N, Ehrmeyer S, Yundt-Pacheco J, Jansen R, Ricós C, et al. Collective opinion paper on findings of the 2010 convocation of experts on laboratory quality. Clin Chem Lab Med 2011;49:793-802.
25. Wu AH, Lu QA, Todd J, Moecks J, Wians F. Short- and long-term biological variation in cardiac troponin I measured with a highsensitivity assay: implications for clinical practice. Clin Chem 2009;55:52-8.
26. deGoma EM, French B, Dunbar RL, Allison MA, Mohler III ER, Budoff MJ. Intraindividual variability of C-reactive protein: the multi-ethnic study of atherosclerosis. Atherosclerosis 2012;224:274-9.
27. Glynn RD, MacFadyen JG, Ridker PM. Tracking of high-sensitivity C-reactive protein after an initially elevated concentration: the JUPITER Study. Clin Chem 2009;55:305-12.
28. Campbell B, Badrick T, Flatman R, Kanowsli D. Limited clinical utility of high-sensitivity plasma C-reactive protein assays. Ann Clin Biochem 2002;39:85-8.